Fukuda Tetsuya, Matsuda Hitoshi, Tanaka Hiroshi, Sanda Yoshihiro, Morita Yoshiaki, Seike Yoshimasa
Department of Radiology, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Kobe J Med Sci. 2018 Jul 3;63(5):E130-E135.
The purpose of this study was to evaluate the efficacy of simultaneous IMA (s-IMA) embolization during the endovascular abdominal aortic aneurysm repair (EVAR).
From July 2007 to January 2011, 189 patients in the no embolization (NE) group underwent EVAR without the indication for s-IMA embolization. Since February 2011 to April 2014, 143 patients have undergone EVAR. Among these patients, 26 patients underwent s-IMA embolism under a predefined indication and constituted the simultaneous embolization (SE) group. The indications for s-IMA embolization were defined by preoperative computed tomography (CT) findings, as follows: (1) the diameter was greater than 2.5 mm and (2) no stenosis due to thrombus or calcification at its orifice.
The incidence of a type II endoleak from the IMA was 3.4% (5/143) in the SE group patients and 13.2% (25/189) in the NE group patients (p = 0.013), and the incidence of a type II endoleak from all branches (i.e., IMA, lumbar, medial sacral arteries) was 15.4% (22/143) in the SE group patients and 32.3% (61/189) in the NE group patients (p = 0.0003). During the follow-up period (range, 6-72 months; mean: 28 months), the reintervention rate for a type II endoleak from the IMA and/or other branches was 9.5% (18/189) in the NE group and 0.6% (1/143) in the SE group (p = 0.0001).
In selected patients, performing an s-IMA embolization, based on CT findings, decreased the incidence of a type II endoleak and reintervention from the IMA and from all branches.
本研究旨在评估在血管腔内腹主动脉瘤修复术(EVAR)期间同时进行肠系膜下动脉(s-IMA)栓塞的疗效。
2007年7月至2011年1月,189例未栓塞(NE)组患者接受了EVAR,无s-IMA栓塞指征。自2011年2月至2014年4月,143例患者接受了EVAR。在这些患者中,26例患者在预定指征下接受了s-IMA栓塞,构成同时栓塞(SE)组。s-IMA栓塞的指征根据术前计算机断层扫描(CT)结果确定如下:(1)直径大于2.5mm;(2)其开口处无因血栓或钙化导致的狭窄。
SE组患者IMA发生II型内漏的发生率为3.4%(5/143),NE组患者为13.2%(25/189)(p = 0.013),SE组患者所有分支(即IMA、腰动脉、骶中动脉)发生II型内漏的发生率为15.4%(22/143),NE组患者为32.3%(61/189)(p = 0.0003)。在随访期间(范围6 - 72个月;平均:28个月),NE组IMA和/或其他分支发生II型内漏的再次干预率为9.5%(18/189),SE组为0.6%(1/143)(p = 0.0001)。
在选定患者中,根据CT结果进行s-IMA栓塞可降低IMA及所有分支发生II型内漏和再次干预的发生率。